
Examining the Potential Price Growth of Blueprint Medicines Corp (BPMC)
Blueprint Medicines Corp’s recently made public that its CHIEF SCIENTIFIC OFFICER Carter Percy H. unloaded Company’s shares for reported $0.34
Blueprint Medicines Corp’s recently made public that its CHIEF SCIENTIFIC OFFICER Carter Percy H. unloaded Company’s shares for reported $0.34
GE Vernova Inc’s recent filing unveils that its Former Officer Jessica Uhl acquired Company’s shares for reported $1.14 million on
In a filing, 8X8 Inc revealed its Director Burton Andrew F. unloaded Company’s shares for reported $12309.0 on Jun 18
AEye Inc’s filing revealed that its Treasurer & CFO Tierney Conor B acquired Company’s shares for reported $2406.0 on Mar
Crinetics Pharmaceuticals Inc’s recently made public that its Chief Scientific Officer Betz Stephen F. unloaded Company’s shares for reported $3.14
Qualcomm, Inc’s recent filing unveils that its CFO & COO Palkhiwala Akash J. unloaded Company’s shares for reported $0.49 million
In a filing, Bank Of New York Mellon Corp revealed its SEVP & General Counsel McCarthy J Kevin unloaded Company’s
Spectrum Brands Holdings Inc’s filing revealed that its Executive Chairman and CEO Maura David M unloaded Company’s shares for reported
Cboe Global Markets Inc’s recently made public that its EVP, COO Isaacson Christopher A unloaded Company’s shares for reported $1.11
Kymera Therapeutics Inc’s recent filing unveils that its Director BAKER BROS. ADVISORS LP acquired Company’s shares for reported $28.84 million